AYA
ARTRYA LIMITED
$3.57
▼ -6.30%
Market cap
$583M
Turnover
$6,057,310
Last price
$3.57
Day change
-6.30%
Announcements
6
Range, past year
Open 2.320 · Low 0.580 · Now 3.570 · High 6.490
Open AYA in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
AYA momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
38/100
Wyckoff phase
Accumulation6d
Trend stage
Neutral
1 Day
-6.3%
1 Week
-5.3%
1 Month
-24.8%
1 Year
+58.7%
RSI
41
Avg daily range
9.0%
ARTRYA LIMITED scores 38 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
What stands out
- Volume 1.7× 60-day avg
- MACD histogram positive & rising
Points to watch
- 60d drawdown -46.2%
- High volatility (ATR 9.0%)
- Risk rating: Very High
- Composite downside risk elevated
AYA announcements
Recent price-sensitive releases.
- 2026-09-01 FY26 Financial Results and Operational Update Presentation Company Presentation | Preliminary Final Report
- 2026-08-19 Appendix 4E and Annual Report to Shareholders Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-29 June Quarterly Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-23 Northeast Georgia Health System goes live with Salix
- 2026-04-30 March Quarterly Activities Report and Appendix 4C
More Health Care stocks
Most traded in the same sector.